Project Grant HT94252410498
Award Date 9/1/24
Completion Date 8/31/27
Dollars Obligated $770K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14627, USA
Similar Awards
- The University of Rochester was awarded a $6,292,954 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "Monitoring and Mitigation of Neurological Injuries to Optimize Resilience After Repetitive Head Impacts (MONITOR RHI)," supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant, with a period...
- Federal Project Grant Award Summary The University of Rochester received a $1.88 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, through September 29, 2029. The grant supports "The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First 3 Years in Children with Duchenne Muscular Dystrophy," a four-year research initiative conducted at the...
- The University of Rochester received a $660,772 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. This grant supports research on anticodon-edited (ACE) transfer RNA (tRNA) treatment as a therapeutic approach for nonsense-mediated Duchenne muscular dystrophy (DMD). The research will be conducted at the University of Rochester's facility in Rochester, New York, and...
- The University of Rochester received a $369,109 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2027. The grant supports research on driving hearing restoration through virally transduced, pharmaceutically activated TERBB2, a therapeutic approach aimed at developing innovative medical solutions for hearing loss. The research will be conducted at the University of...
- Federal Grant Award Summary The University of Rochester received a $1,173,575 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. This award funds research on Anticodon-Edited (ACE) transfer RNA (tRNA) treatment for nonsense-mediated Duchenne muscular dystrophy (DMD), a genetic disorder affecting muscle function. The research will be conducted at the University of...
- The University of Rochester received a $812,602 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMAGING CANCER MICROENVIRONMENT HOT SPOTS INVOLVED IN PROGRESSION OF MYELODYSPLASTIC SYNDROMES." The research, which will take place from May 2024 to May 2027, aims to improve understanding of the cancer microenvironment and its role in the progression of myelodysplastic syndromes, a group of...
- The University of Rochester received a $2.93 million cooperative agreement award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2022 through July 31, 2026. The award, titled "LONGITUDINAL END POINT OPTIMIZATION TO PROVIDE ASSESSMENTS OF RELEVANT DRUGS," will support the University's work to transform healthcare for service members and the public through innovative biomedical...
- The University of Rochester received a $385,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award, issued on May 1, 2021 and concluding on April 30, 2023, will support the development of UR238, a small-molecule inhibitor of HE4 being investigated for treatment of ovarian cancer. Through this funding, the University of Rochester will conduct research towards transforming...
- The University of Rochester will receive $1,501,044 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to investigate whether improvement of sleep and lymphatic function can reduce the risk of developing Alzheimer's disease-related dementia after traumatic brain injury. Specifically, the University of Rochester will conduct research from July 1, 2022 to June 30, 2025 to transform military and public health through...
- The University of Rochester will receive $770,000 from the Defense Health Agency under a three-year Project Grant award titled "Estrogen Promotes Lymphangioleiomyomatosis (LAM) Indirectly Through Stimulation of Innate Immunity." The grant funds basic, applied, and advanced biomedical research from July 1, 2023 to June 30, 2026. The research will investigate how estrogen may indirectly promote LAM, a rare lung disease, through stimulation of the innate immune system. The award is part...